Medicine Inventory Management Practices in Floating Hospitals in Indonesia

The purpose of the study is to discuss the challenges and organizational differences in pharmaceutical procurement between RSA dr. Lie Dharmawan and RSA Nusa Waluya II. RSA dr. Lie Dharmawan faces issues such as insufficient human resources and overlapping roles, resulting in ineffective organizational structure implementation. In contrast, RSA Nusa Waluya II has a well-structured organization with clearly defined roles and responsibilities. The pharmaceutical procurement process at RSA dr. Lie Dharmawan suffers from an imprecise timeline schedule, complicating medicine classification. doctorSHARE's healthcare services adhere to its internal policies, ensuring accessible and affordable healthcare aligned with its standards. Although internal controls were established from the beginning, program evaluations are informally conducted, lacking a formal review process. At RSA dr. Lie Dharmawan, task segregation is inadequate, particularly in pharmaceutical procurement, classification, and stocktaking, which are not managed by a pharmacist despite the use of an ERP system. In terms of financial transparency and accountability, doctorSHARE performs well, with financial reports separated by funding sources and accountability to donors maintained through specific reporting formats. doctorSHARE undergoes audits by donors, including UNICEF and UNFPA, and has established internal audits and annual external audits to ensure financial transparency and integrity.